HIV Scientific Papers

Ibalizumab: first global approval.
2018
Drugs.
Markham A.
78(7):781-785.
Ibalizumab in multidrug-resistant HIV - accepting uncertainty.
2018
N Engl J Med.
Sheikh V, Murray JS, Sherwat A.
379(7):605-607.
Ibalizumab susceptibility in patient HIV isolates resistant to antiretrovirals [abstract].
2018
Top Antivir Med.
Weinheimer S, Cohen Z, Marsolais C, Lewis S.
"26(suppl 1):239s. Proceedings of the 2018 Conference on Retroviruses and Opportunistic Infections. "
Ibalizumab susceptibility in patient HIV isolates resistant to antiretrovirals.
2018
Weinheimer S, Cohen Z, Marsolais C, Lewis S.
Poster #561 presented at: Conference on Retroviruses and Opportunistic Infections; March 4-7, 2018; Boston, Massachusetts, USA.
Long-acting ibalizumab susceptibility in multi-drug resistant HIV patients [abstract].
2017
Weinheimer S, Marsolais C, Cohen Z, Lewis S.
#MOPEB0352. Presented at: 9th IAS Conference on HIV Science; July 23-26 2017; Paris, France.